LivingGLP1
Study S002133

Effects of KATP Channel Blockers on GLP-1 and Its Analogues' Mediated Microvascular Function

Registration

Registration
NCT01934816
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
TRIPLE
Status
TERMINATED
Enrollment
2
Start
2013-06
Primary completion
2015-01
Lead sponsor
Katarina Kos
Conditions
Healthy Subjects
Interventions
OTHER:Intradermal injections of GLP-1 and its analogues
Results posted
FALSE
Secondary identifiers
REGISTRY:1308823; OTHER:13/SW/0010

Registered primary outcomes

  • Change in skin blood flow to GLP-1 and its analogues [6 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.